
Chinese General Practice ›› 2024, Vol. 27 ›› Issue (09): 1109-1117.DOI: 10.12114/j.issn.1007-9572.2023.0483
Special Issue: 儿科最新文章合辑; 运动相关研究最新文章合辑; 心血管最新文章合辑; 生活方式干预相关研究最新文章合辑; 肥胖/减重最新文章合辑 ; 女性健康最新文章合辑
• Original Research • Previous Articles Next Articles
Received:2023-07-31
Revised:2023-10-24
Published:2024-03-20
Online:2023-12-19
Contact:
XU Baichao
通讯作者:
徐百超
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0483
| 组别 | 人数 | 年龄(岁) | 身高(cm) | 体质量(kg) |
|---|---|---|---|---|
| 对照组 | 24 | 15.0±0.8 | 153.48 ± 4.34 | 68.78 ± 1.57 |
| 试验组 | 20 | 14.8±0.8 | 153.40± 5.17 | 69.05 ± 1.85 |
| t值 | 0.670 | 0.054 | -0.514 | |
| P值 | 0.509 | 0.957 | 0.610 |
Table 1 Comparison of general characteristics of female adolescents between the control group and experimental group
| 组别 | 人数 | 年龄(岁) | 身高(cm) | 体质量(kg) |
|---|---|---|---|---|
| 对照组 | 24 | 15.0±0.8 | 153.48 ± 4.34 | 68.78 ± 1.57 |
| 试验组 | 20 | 14.8±0.8 | 153.40± 5.17 | 69.05 ± 1.85 |
| t值 | 0.670 | 0.054 | -0.514 | |
| P值 | 0.509 | 0.957 | 0.610 |
| 组别 | 人数 | BFR(%) | WC(cm) | BMI(kg/m2) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 34.07±0.85 | 34.16±0.72 | -1.325 | 0.164 | 87.0±1.0 | 87.0±1.8 | -1.269 | 0.208 | 29.0±1.3 | 29.3±1.8 | -1.481 | 0.153 |
| 试验组 | 20 | 33.24±0.26 | 30.52±1.01 | 13.377 | <0.001 | 87.0±0.9 | 85.1±0.8 | 6.275 | <0.001 | 29.0±1.1 | 28.8±2.1 | 0.467 | 0.646 |
| t值 | 2.160 | 14.904 | -1.956 | 9.462 | 0.039 | 0.056 | |||||||
| P值 | 0.150 | <0.001 | 0.118 | <0.001 | 0.970 | 0.842 | |||||||
Table 2 Comparison of BFR,WC and BMI between the control group and experimental group
| 组别 | 人数 | BFR(%) | WC(cm) | BMI(kg/m2) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 34.07±0.85 | 34.16±0.72 | -1.325 | 0.164 | 87.0±1.0 | 87.0±1.8 | -1.269 | 0.208 | 29.0±1.3 | 29.3±1.8 | -1.481 | 0.153 |
| 试验组 | 20 | 33.24±0.26 | 30.52±1.01 | 13.377 | <0.001 | 87.0±0.9 | 85.1±0.8 | 6.275 | <0.001 | 29.0±1.1 | 28.8±2.1 | 0.467 | 0.646 |
| t值 | 2.160 | 14.904 | -1.956 | 9.462 | 0.039 | 0.056 | |||||||
| P值 | 0.150 | <0.001 | 0.118 | <0.001 | 0.970 | 0.842 | |||||||
| 组别 | 人数 | SBP | DBP | PP | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 132±3 | 132±3 | -1.106 | 0.312 | 82±1 | 82±1 | -1.40 | 0.890 | 50±4 | 50±3 | -1.031 | 0.142 |
| 试验组 | 20 | 133±3 | 127±1 | 7.651 | <0.001 | 82±1 | 81±1 | 4.053 | 0.001 | 51±3 | 46±1 | 6.795 | <0.001 |
| t值 | -7.430 | 9.179 | 0.807 | 4.953 | -0.923 | 1.893 | |||||||
| P值 | 0.462 | <0.001 | 0.424 | <0.001 | 0.361 | 0.065 | |||||||
Table 3 Comparison of blood pressure of female adolescents between the control group and experimental group
| 组别 | 人数 | SBP | DBP | PP | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 132±3 | 132±3 | -1.106 | 0.312 | 82±1 | 82±1 | -1.40 | 0.890 | 50±4 | 50±3 | -1.031 | 0.142 |
| 试验组 | 20 | 133±3 | 127±1 | 7.651 | <0.001 | 82±1 | 81±1 | 4.053 | 0.001 | 51±3 | 46±1 | 6.795 | <0.001 |
| t值 | -7.430 | 9.179 | 0.807 | 4.953 | -0.923 | 1.893 | |||||||
| P值 | 0.462 | <0.001 | 0.424 | <0.001 | 0.361 | 0.065 | |||||||
| 组别 | 人数 | FPG(μU/mL) | 胰岛素(mg/dL) | HOMA-IR | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 89.07±2.87 | 88.87±6.29 | 0.282 | 0.781 | 14.79±1.31 | 14.58±1.08 | 1.351 | 0.190 | 3.25±0.31 | 3.20±0.33 | 1.181 | 0.250 |
| 试验组 | 20 | 90.24±0.79 | 87.58±1.27 | 8.367 | <0.001 | 13.54±0.84 | 9.82±0.89 | 12.898 | <0.001 | 3.02±0.19 | 2.12±0.20 | 14.271 | <0.001 |
| t值 | -1.758 | 9.326 | 2.166 | 15.641 | 0.896 | 12.828 | |||||||
| P值 | 0.086 | <0.001 | 0.160 | <0.001 | 0.372 | <0.001 | |||||||
Table 4 Comparison of FPG,insulin and HOMA-IR of female adolescents between the control group and experimental group
| 组别 | 人数 | FPG(μU/mL) | 胰岛素(mg/dL) | HOMA-IR | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 89.07±2.87 | 88.87±6.29 | 0.282 | 0.781 | 14.79±1.31 | 14.58±1.08 | 1.351 | 0.190 | 3.25±0.31 | 3.20±0.33 | 1.181 | 0.250 |
| 试验组 | 20 | 90.24±0.79 | 87.58±1.27 | 8.367 | <0.001 | 13.54±0.84 | 9.82±0.89 | 12.898 | <0.001 | 3.02±0.19 | 2.12±0.20 | 14.271 | <0.001 |
| t值 | -1.758 | 9.326 | 2.166 | 15.641 | 0.896 | 12.828 | |||||||
| P值 | 0.086 | <0.001 | 0.160 | <0.001 | 0.372 | <0.001 | |||||||
| 组别 | 人数 | Laps(次) | MAS(km/h) | VO2max(mL·kg-1·min-1) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 25.00±0.97 | 24.67±1.08 | 1.261 | 0.231 | 9.52±0.12 | 9.55±0.14 | -1.239 | 0.228 | 37.03±1.09 | 37.14±0.77 | -0.684 | 0.501 |
| 试验组 | 20 | 21.90±1.16 | 28.04±0.65 | -23.915 | <0.001 | 9.56±0.69 | 9.87±0.49 | -21.430 | <0.001 | 36.88±0.67 | 39.00±0.44 | -11.832 | <0.001 |
| t值 | 0.843 | -12.153 | -1.111 | -9.519 | 0.520 | -9.660 | |||||||
| P值 | 0.386 | <0.001 | 0.273 | <0.001 | 0.606 | <0.001 | |||||||
Table 5 Comparison of Laps,MAS and VO2max of female adolescents between the control group and experimental group
| 组别 | 人数 | Laps(次) | MAS(km/h) | VO2max(mL·kg-1·min-1) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | 干预前 | 干预后 | t配对值 | P值 | ||
| 对照组 | 24 | 25.00±0.97 | 24.67±1.08 | 1.261 | 0.231 | 9.52±0.12 | 9.55±0.14 | -1.239 | 0.228 | 37.03±1.09 | 37.14±0.77 | -0.684 | 0.501 |
| 试验组 | 20 | 21.90±1.16 | 28.04±0.65 | -23.915 | <0.001 | 9.56±0.69 | 9.87±0.49 | -21.430 | <0.001 | 36.88±0.67 | 39.00±0.44 | -11.832 | <0.001 |
| t值 | 0.843 | -12.153 | -1.111 | -9.519 | 0.520 | -9.660 | |||||||
| P值 | 0.386 | <0.001 | 0.273 | <0.001 | 0.606 | <0.001 | |||||||
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
张艺宏,徐峻华,何本祥. 运动机能评定理论与方法[M]. 北京:科学出版社,2018.
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [1] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [2] | ZHANG Ke, ZENG Xianchang, ZOLZAYA Enkhzaya, ZHU Yelin, HUANG Yiwen, LIU Zhenxiu, TAO Feng. Effect of Xiere Xingpi Yin on Eating Behaviors and Weight-related Outcomes in Patients with Obesity: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(20): 2759-2765. |
| [3] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [4] | WU Zhen, XI Yaqi, HU Linlin. Characteristics of Policy Instrument Selection and Combination for Weight Management in China: a Content Analysis of National Policy Documents (2016-2025) [J]. Chinese General Practice, 2026, 29(20): 2766-2774. |
| [5] | CHEN Xiangyang, HUANG Hongmei, LI Sheyu. Prevention and Management of Adult Obesity: Progress and Trends from Six Keywords in 2025 [J]. Chinese General Practice, 2026, 29(20): 2753-2758. |
| [6] | TANG Lijuan, QI Qi, ZHANG Fan, GAO Yifu, CAO Yajing, YUE Fujuan, GAO Jinchai, LIU Xiaoli. Characterisation of the Prevalence of Overweight/Obesity among Residents Aged 18-44 Years in Hebei Province in 2013 and 2020 [J]. Chinese General Practice, 2026, 29(19): 2695-2704. |
| [7] | LI Yachan, YANG Yang, XU Qianting, KE Tingyu. Association between the Chinese Visceral Adiposity Index and Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(18): 2482-2488. |
| [8] | LI Simin, ZHANG Tingting, WANG Kunbo, YANG Jianzhou, PING Weiwei. Effects of Exercise Dosage on Elderly Patients with Sarcopenia: a Meta-analysis [J]. Chinese General Practice, 2026, 29(17): 2400-2409. |
| [9] | Chinese Nutrition Society Obesity Prevention and Control Branch. Chinese Guidelines for Behavioral and Lifestyle Interventions for Obesity [J]. Chinese General Practice, 2026, 29(16): 2113-2139. |
| [10] | LI Jiali, LIU Fan, KE Lixin, LI Huijuan, WANG Haibo, ZHAO Xiaoxiao, ZHAO Xinke, LU Cuncun. Disease Burden of Obesity among Individuals Aged 60 and above Globally and in China from 1990 to 2021: Trend Analysis and Model-based Projection [J]. Chinese General Practice, 2026, 29(15): 2067-2076. |
| [11] | CHEN Xiaolong, JIN Jing, HUA Jialu, LI Yuyu, PAN Youjia, PAN Qi, TU Chunjing, WANG Ping. Study on the Optimal Time-use Composition of 24-hour Movement Behaviors for Obesity Prevention in College Students [J]. Chinese General Practice, 2026, 29(12): 1525-1532. |
| [12] | YANG Lei, GUAN Hua. Application Progress of Generative Artificial Intelligence in Weight Management [J]. Chinese General Practice, 2026, 29(12): 1533-1540. |
| [13] | YAN Manli, ZHANG Baoqing, HUANG Lei, LI Xiang. A New Chapter in Obesity Treatment: Mechanisms and Clinical Research Progress of Multi-target Peptide Agonists [J]. Chinese General Practice, 2026, 29(12): 1511-1519. |
| [14] | HE Zhiguang, QIU Shanjiao, CHEN Zhang, LI Anchun, HUANG Wenjing. Interpretation and Discussion of the RACGP Guidelines for Preventive Activities in General Practice: Screening for Weight Issues and Preventive Strategies [J]. Chinese General Practice, 2026, 29(12): 1505-1510. |
| [15] | GU Handong, LU Hongrun, GU Keyi, HAN Zheng, YANG Fei, FU Xiaoya, WANG Weiqiang. Association Research between Relative Fat Mass and the Incidence Risk of Cardiometabolic Multimorbidity [J]. Chinese General Practice, 2026, 29(11): 1456-1462. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||